Newton Biocapital
Investor profile
Newton Biocapital has backed 3 European tech companies across 3 funding rounds between 2017 and 2023, joining rounds totalling €167M. Most active in Healthtech. Data as of Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2017–2023
7 yrs
Total round €
€167M
sum of rounds joined
Deals by year
distinct rounds / yearNewton Biocapital — deals by year — interactive chart.
Data table
| Newton Biocapital — deals by year | |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2023 | 1 |
Top sectors
by dealsNewton Biocapital — top sectors — interactive chart.
Data table
| Newton Biocapital — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsNewton Biocapital — stages — interactive chart.
Data table
| Newton Biocapital — stages | |
|---|---|
| Series A | 2 |
| Series B | 1 |
Countries
by dealsNewton Biocapital — countries — interactive chart.
Data table
| Newton Biocapital — countries | |
|---|---|
| Belgium | 2 |
| France | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Acticor biotech | France | 1 | €153M |
| Synergia | Belgium | 1 | €8.1M |
| DeuterOncology | Belgium | 1 | €5.7M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Acticor biotech | Series B | €153M | 2018-11 |
| Synergia | Series A | €8.1M | 2018-01 |
| DeuterOncology | Series A | €5.7M | 2023-01 |